There are 2789 resources available
1409P - Cost-effectiveness of pembrolizumab plus platinum and fluoropyrimidine-based chemotherapy as first-line treatment of advanced esophageal cancer in the United States
Presenter: Tingting Qu
Session: ePoster Display
1410P - Gastric cancer: Data from the AGAMENON-SEOM study
Presenter: Ismael Macias Declara
Session: ePoster Display
1331P - Open-label phase I/II study evaluating the tolerability and anti-tumor activity of selinexor (SEL) and docetaxel (DTX) in non-small cell lung cancer (NSCLC)
Presenter: Alona Zer
Session: ePoster Display
1332P - A randomized phase II trial of standard versus low-dose nab-paclitaxel for previously treated advanced non-small cell lung cancer (JMTO LC14-01)
Presenter: Susumu Takeuchi
Session: ePoster Display
1413P - Antibiotic administration and outcome of patients with advanced gastric cancer receiving programmed death-1 inhibitors or with single-agent chemotherapy
Presenter: Minkyu Jung
Session: ePoster Display
1414P - Helicobacter pylori infection is associated with clinical benefits of anti-PD-1/PD-L1-based therapies in advanced gastric/esophagogastric junction cancer: A real world multicenter observational study
Presenter: Qing Wei
Session: ePoster Display
Resources:
Abstract
1490P - Depression and anxiety in prostate cancer patients: Analysis of possible factors and correlations
Presenter: Paraskevas Kosmidis
Session: ePoster Display
1491P - Assessment of psychiatric disorder in patients with metastatic breast cancer: A cross-sectional study
Presenter: Raquel Basto
Session: ePoster Display
1335P - Updated results from a phase I/II study of anlotinib plus docetaxel vs docetaxel as second-line treatment of advanced non-small cell lung cancer (NSCLC)
Presenter: Yong Fang
Session: ePoster Display